CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Guide to the Application of Genotyping to Tuberculosis Prevention and Control

Return to Genotyping Main Menu

Tuberculosis Genotyping Case Studies: How TB Programs Have Used Genotyping

Algorithm to Detect False-Positive Cultures

Genotyping can help identify instances of incorrect TB diagnoses that are based on false-positive cultures. Incorrect diagnoses can result from laboratory cross-contamination of cultures, mislabeling of patient specimens, collection errors, and reporting errors. Such errors occur in an estimated 1%–3% of all reported cases of TB, and as many as 300 persons per year in the United States may be started erroneously on anti-tuberculosis treatment. Universal genotyping permits TB programs to establish simple algorithms to flag suspected errors.

The California Department of Health Services, in collaboration with San Francisco General Hospital, Santa Clara Valley Medical Center, and Solano County Public Health Laboratory, evaluated this type of algorithm to find methods to decrease the occurrence of laboratory cross-contamination (Jasmer 2002).

During the study period from January 1998 through June 1999, cultures for 296 patients were positive for M. tuberculosis, and cultures for ten patients met one or more of the criteria for possible false-positive cultures. A review by a panel of experts determined that TB was misdiagnosed for six patients (representing 2% of all patients with cultures positive for M. tuberculosis) because of laboratory cross-contamination. In four of the six cases, contamination probably occurred when reagents were dispensed from a common flask. This practice was discontinued on the basis of the findings of this study. (See Chapter 6, Applying Genotyping Results to Tuberculosis Control Practices, for more information on investigating false-positive cultures.)

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov